KS

KMC Speciality Hospitals (India) Ltd

Q4 FY26Healthcare Services

KMC Speciality Hospitals (India) Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 investor presentation: what the company reported on revenue, margins and projects.

Price₹156
Market cap₹2.5K Cr
P/E43.9
Updated25 Sept 2026
Read4 min read

Based on KMC Speciality Hospitals (India) Ltd's Q4 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.

The short version

Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) - Q4 FY’26 Total Income: INR 84.2 Cr, up 36% YoY from INR 61.7 Cr in Q4 FY’25 (Pages 14, 15) - Q4 FY’26 In-Patient Volumes: 4,823, up 17% YoY from 4,137 in Q4 FY’25 (Page 16) - Q4 FY’26 Out-Patient Volumes: 55,630, up 32% YoY from 42,034 in Q4 FY’25 (Page 16) - Q4 FY’26 Occupied Beds approx. Q4 FY'26 EBITDA: INR 27.8 Cr, up 71% year-on-year from INR 16.2 Cr in Q4 FY'25.

From KMC Speciality Hospitals (India) Ltd's Q4 FY26 earnings-call transcript · updated 25 Sept 2026.

Revenue & Sales Performance

  • Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20)
  • Q4 FY’26 Total Income: INR 84.2 Cr, up 36% YoY from INR 61.7 Cr in Q4 FY’25 (Pages 14, 15)
  • Q4 FY’26 In-Patient Volumes: 4,823, up 17% YoY from 4,137 in Q4 FY’25 (Page 16)
  • Q4 FY’26 Out-Patient Volumes: 55,630, up 32% YoY from 42,034 in Q4 FY’25 (Page 16)

2 more points management made on revenue & sales performance

Profitability & Margins

See what KMC Speciality Hospitals (India) Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • New facility "Maa Kauvery" with 200 beds announced and operational from January 2024 (Page 8, 32).
  • Loan availed for "Maa Kauvery" facility reflected in financials from FY’24; total borrowings for new facility INR 71.03 Cr as of FY’26 (Pages 29, 31, 21).
  • Capacity expansion from 205 beds to 330 beds by FY’25; census beds increased to 330 by FY’25 and maintained in FY’26 (Pages 33, 24).
  • Property, Plant and Equipment investments increased to support expansion, with gross PPE rising significantly from FY’23 onwards, reaching INR ~235 Cr by FY’26 (Pages 31, 20).

2 more points management made on capital expenditure plans

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

5x potential
Rev 1Mar 1
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 2
5
Rev 2Mar 2
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what KMC Speciality Hospitals (India) Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The investor presentation for KMC Speciality Hospitals (India) Ltd does not report or mention any details regarding order book, order inflow, or pending orders. The presentation primarily focuses on financial performance, operational metrics, cash flow, balance sheet data, and hospital operational parameters. There is no specified information or data related to orders in the entire document.

KMC Speciality Hospitals (India) Ltd — Quarterly revenue & net profit

Revenue Net profit
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025

Reported quarterly figures (₹ Cr). Latest: revenue ₹82 Cr, net profit ₹14 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What KMC Speciality Hospitals (India) Ltd's management said in earlier quarters

Others in Healthcare Services this season

  • Star Imaging (Q4 FY26)

    Capex planned for FY27 is around INR 20 to 25 crores, mainly towards new centres and equipment. Key concall takeaways from Star Imaging's Q4 FY26 earnings call…

  • Gaudium IVF (Q4 FY26)

    Revenue growth seen in FY26: INR 104.35 crore, a 47.56% increase from FY25. Key concall takeaways from Gaudium IVF's Q4 FY26 earnings call — and how it ranks…

  • Apollo Hospitals Enterprise Ltd (Q4 FY26)

    30% growth currently driven by top 5 markets; expansion planned into new markets. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q4 FY26 earnings…

  • Health X Platform Ltd (Q4 FY26)

    Northeast operations growing 50%+ year-on-year and Northern India 25–30%, with plans for 5–7% market share in 2-3 years (Page 10). Key concall takeaways from…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were KMC Speciality Hospitals (India) Ltd Q4 FY26 results?

Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) - Q4 FY’26 Total Income: INR 84.2 Cr, up 36% YoY from INR 61.7 Cr in Q4 FY’25 (Pages 14, 15) - Q4 FY’26 In-Patient Volumes: 4,823, up 17% YoY from 4,137 in Q4 FY’25 (Page 16) - Q4 FY’26 Out-Patient Volumes: 55,630, up 32% YoY from 42,034 in Q4 FY’25 (Page 16) - Q4 FY’26 Occupied Beds approx. Q4 FY'26 EBITDA: INR 27.8 Cr, up 71% year-on-year from INR 16.2 Cr in Q4 FY'25.

What is KMC Speciality Hospitals (India) Ltd share price analysis?

KMC Speciality Hospitals (India) Ltd currently shows a neutral. The stock trades at a P/E of 43.9 with a market cap of ₹2,451 Cr. Investors should review the full earnings analysis for detailed insights.

Is KMC Speciality Hospitals (India) Ltd planning capital expenditure?

New facility "Maa Kauvery" with 200 beds announced and operational from January 2024 (Page 8, 32).

Keep KMC Speciality Hospitals (India) Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.